Publications by authors named "Johanna Oechtering"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

483

Total Likes

127

Extended Reach

763,819

Social Features

37
S
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Stephanie Meier, Eline A J Willemse, Sabine Schaedelin, Johanna Oechtering, Johannes Lorscheider, Lester Melie-Garcia, Alessandro Cagol, Muhamed Barakovic, Riccardo Galbusera, Suvitha Subramaniam

JAMA Neurol· March 2023

Videos about Article: user user

2 3 35 3 18

View All Article and Social Media Activity
S
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, Johanna Oechtering, Sabine Schaedelin

Ann Clin Transl Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.
Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin, Johanna Oechtering

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin, Johanna Oechtering

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.
Xinjie Chen, Po-Jui Lu, Mario Ocampo-Pineda, Alessandro Cagol, Sabine Anna Schaedelin, Johanna Oechtering

Neurol Neuroimmunol Neuroinflamm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
Roberto Furlan, Sabine Schaedelin, Jette Lautrup Frederiksen, Mitsuru Watanabe, Fredrik Piehl, Johanna Oechtering

Brain· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort.
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, Pascal Benkert, Cathrine Axfors, Johanna Oechtering

Neurol Clin Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, Amit Bar-Or, Viviane Bohner-Lang, Johanna Oechtering

Mult Scler· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.
Nicolás Fissolo, Sabine Schaedelin, Luisa M Villar, Jan D Lünemann, Jorge Correale, Johanna Oechtering

JAMA Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, Pascal Benkert, Lester Melie-Garcia, Johanna Oechtering

J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal neuronal loss and progression independent of relapse activity in multiple sclerosis.
Federico Burguet Villena, Nuria Cerdá-Fuertes, Lisa Hofer, Sabine Schädelin, Shaumiya Sellathurai, Johanna Oechtering

J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis.
Daniel E Radford-Smith, Abi G Yates, Tereza Kacerova, Marjo Nylund, Marcus Sucksdorff, Johanna Oechtering

BMJ Neurol Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.
Johanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, Aleksandra Maleska Maceski, Lester Melie-Garcia

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple Sclerosis.
Johannes Raffael Dahl, Alicia Weier, Christopher Winter, Maik Hintze, Veit Rothhammer, Johanna Oechtering

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort.
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, Johannes Lorscheider, Riccardo Galbusera

Mult Scler J Exp Transl Clin· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Pascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin, Johanna Oechtering, Amar Zadic

Ann Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial.
Perrine Janiaud, Chiara Zecca, Anke Salmen, Pascal Benkert, Sabine Schädelin, Johanna Oechtering

Trials· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Ilaria Callegari, Johanna Oechtering, Mika Schneider, Sylvain Perriot, Amandine Mathias

Brain· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis.
Johanna Oechtering, Kerstin Stein, Sabine A Schaedelin, Aleksandra M Maceski, Annette Orleth

Neurol Neuroimmunol Neuroinflamm· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Alessandro Cagol, Pascal Benkert, Lester Melie-Garcia, Sabine A Schaedelin, Selina Leber, Johanna Oechtering

Neurology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin, W John Boscardin, Christian Cordano, Johanna Oechtering

JAMA Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis.
David Leppert, Mitsuru Watanabe, Sabine Schaedelin, Fredrik Piehl, Roberto Furlan, Johanna Oechtering

J Neurol Neurosurg Psychiatry· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study.
Ahmed Abdelhak, Franziska Petermeier, Pascal Benkert, Sabine Schädelin, Johanna Oechtering

Lancet Neurol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands.
Fay Probert, Tianrong Yeo, Yifan Zhou, Megan Sealey, Siddharth Arora, Johanna Oechtering

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study.
Manina M Etter, Tomás A Martins, Laila Kulsvehagen, Elisabeth Pössnecker, Wandrille Duchemin, Johanna Oechtering

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis